Pharmacokinetics of transdermal buprenorphine patch in the elderly
- PMID: 22706617
- PMCID: PMC3548110
- DOI: 10.1007/s00228-012-1320-8
Pharmacokinetics of transdermal buprenorphine patch in the elderly
Abstract
Purpose: Transdermal buprenorphine patches provide comparable pain relief to that of low-potency opioids in elderly individuals. However, specific data on their use in elderly individuals is limited. This study investigated and compared the PK of buprenorphine transdermal patches in elderly (≥ 75 years) versus younger (50-60 years) individuals.
Methods: This was a multiple-dose, open-label, parallel-group study in healthy volunteers split into two age groups (younger, 50-60 years; elderly, ≥ 75 years) with 37 individuals in each. Study participants received two consecutive 7-day buprenorphine 5 μg/h transdermal patch applications, and blood samples were collected on the week of the second patch application [day 7 (predose), days 8, 9, 10, 12, and 14] to determine PK at steady state. Pharmacokinetic parameters were determined for buprenorphine and norbuprenorphine. Safety was assessed by analyzing adverse events, hematology, clinical chemistry, urine analysis, vital signs, electrocardiogram (ECG), and physical examinations.
Results: The area under the plasma concentration-time curve at steady state (AUC(tau)), measured over one dosing interval, was similar for elderly [mean ± standard deviation (SD) 9,940 pg/h/ml (4,827 pg/h/ml] and younger [mean ± SD 11,309 (3,670 pg/h/ml] individuals. Bioequivalence was not demonstrated between groups, which may be attributable to the relatively high level of variability in individual plasma profiles. More adverse events were reported by younger (216) than elderly (164) study participants.
Conclusions: No dosage alterations are necessary for PK reasons when treating elderly people with buprenorphine transdermal patches.
Figures


Comment in
-
Transdermal buprenorphine-interesting observations on the metabolite norbuprenorphine levels in elderly subjects.Eur J Clin Pharmacol. 2013 Aug;69(8):1607-8. doi: 10.1007/s00228-013-1508-6. Epub 2013 Apr 16. Eur J Clin Pharmacol. 2013. PMID: 23588566 No abstract available.
-
Response to the letter to the editor by Dr. Srinivas on the recent publication of Al-Tawil et al. on the pharmacokinetics of transdermal buprenorphine patch in the elderly.Eur J Clin Pharmacol. 2013 Aug;69(8):1609-10. doi: 10.1007/s00228-013-1509-5. Epub 2013 Apr 16. Eur J Clin Pharmacol. 2013. PMID: 23588567 Free PMC article. No abstract available.
Similar articles
-
Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.Clin Ther. 2007 Aug;29(8):1591-606. doi: 10.1016/j.clinthera.2007.08.001. Clin Ther. 2007. PMID: 17919542 Clinical Trial.
-
Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.Clin Ther. 2009 Mar;31(3):503-13. doi: 10.1016/j.clinthera.2009.03.001. Clin Ther. 2009. PMID: 19393841 Clinical Trial.
-
Is buprenorphine transdermal patch equally safe and effective in younger and elderly patients with osteoarthritis-related pain? Results of an age-group controlled study.Curr Med Res Opin. 2014 Apr;30(4):575-87. doi: 10.1185/03007995.2013.873714. Epub 2013 Dec 23. Curr Med Res Opin. 2014. PMID: 24320787
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.Drugs. 2011 Dec 24;71(18):2491-509. doi: 10.2165/11208250-000000000-00000. Drugs. 2011. PMID: 22141389 Review.
Cited by
-
Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain.Pain Ther. 2019 Dec;8(2):187-201. doi: 10.1007/s40122-019-0126-0. Epub 2019 May 17. Pain Ther. 2019. PMID: 31102146 Free PMC article. Review.
-
Management of pain in cancer patients - an update.Ecancermedicalscience. 2024 Dec 12;18:1821. doi: 10.3332/ecancer.2024.1821. eCollection 2024. Ecancermedicalscience. 2024. PMID: 40171458 Free PMC article.
-
Managing Pain in the Older Cancer Patient.Curr Oncol Rep. 2019 Nov 14;21(11):100. doi: 10.1007/s11912-019-0854-7. Curr Oncol Rep. 2019. PMID: 31728653 Review.
-
Comparison of Efficacy and Safety of Transdermal Buprenorphine Patch and Conventional Analgesics in Intra-capsular Femur Neck Fracture Post Hemiarthroplasty.Indian J Orthop. 2022 Jun 25;56(8):1363-1369. doi: 10.1007/s43465-022-00668-7. eCollection 2022 Aug. Indian J Orthop. 2022. PMID: 35928664 Free PMC article.
-
Application of a buprenorphine transdermal patch for the perioperative analgesia in patients who underwent simple lumbar discectomy.Medicine (Baltimore). 2017 May;96(20):e6844. doi: 10.1097/MD.0000000000006844. Medicine (Baltimore). 2017. PMID: 28514299 Free PMC article. Clinical Trial.
References
-
- Swedish Medical Products Agency. (2004) Treatment of osteoarthritis [in Swedish]. 13:19-25
-
- NICE Clinical Guideline for care and management in adults – Osteoarthritis (http://www.scribd.com/doc/2663331/NICE-guideline - accessed October 2011)
-
- American Geriatric Society (AGS) Panel on pharmacological management of persistent pain in older persons. J Am Geriatc Soc. 2009;67:1331–46. - PubMed
-
- The Swedish Council on Technology Assessment in Healthcare. (2009) Pharmaceutical treatments among the elderly – how can it be improved? [in Swedish]. Stockholm, Sweden: Swedish Council on Technology Assessment in Healthcare (www.sbu.se)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources